Rezultati pretraživanja
  1. 7. pro 2019.

    vs ... still haven’t gotten any taller!

  2. 9. pro 2018.

    Amazing era for hematology

  3. 5. pro 2018.

    It was a very great opportunity and experience to present my Ph.D. project at . Thank you to & – mjesto: San Diego Convention Center

  4. 5. kol 2019.

    The results of the PAUSE study on periop management of patients on DOACs (abstract at ) has officially been published today in ! "Perioperative Management of Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant"

  5. 10. pro 2018.

    I’m excited and honored to receive a 2019 Junior Faculty Scholar Award from the American Society of Hematology. Feeling inspired by all the great research I saw a week ago at .

  6. 7. pro 2018.

    Energized after , is recruiting postdocs to join our team!

  7. . discusses the results of a new study that showed oral anticoagulants are effective at preventing blood clots in high-risk cancer patients.

  8. 4. pro 2018.
  9. 7. pro 2019.

    Come see my poster on contributions from low and middle-income countries to later today! #2123 will be giving high fives for free 🖐🏻

  10. 4. pro 2018.

    Just when you think that flying ✈️ can’t get more silly, makes every attendee from remove the two-pound Education Book 📖 from their checked bag 🧳 and carry it on, because their security scanners can’t handle the density (of the knowledge! 🧠).

    Prikaži ovu nit
  11. 13. pro 2018.

    Drs. Lamanna, Friedberg and myself discussing the advances made in CLL at . It was a BIG year! Lot's to discuss.

  12. For the first time, researchers have found an association between the makeup of the microorganisms in the body before a bone marrow transplant and a patient’s survival afterward.

  13. 5. pro 2018.

    Check out ASH Summary from Drs. Durie, Mikhael & Mateos and the Patient Team

  14. 5. pro 2018.

    late breaking abstract showed newly FDA approved Emapalumab for

  15. The latest ep of our biotech podcast is out! On the docket this week: 🔹 tries to make biotech IPO history 🔹 and the quest to cure sickle cell disease 🔹 on 's drug approval dreaded by patients

  16. 5. pro 2018.
  17. 9. pro 2018.

    It was great to see the results of the PAUSE trial that was presented at about surgery in patients on undergoing surgery or procedures. Temporary discontinuation is safe and effective with no bridging needed. Confirms our clinical practice.

  18. 7. pro 2019.

    No Len? No prob! CD98hc as a potential target in IMiD resistant MM. turns out Len targets CRBN to inhibit it’s function as a co-chaperone of HSP90

  19. 31. ožu 2019.

    After , so looking forward to present our survey at to this audience, as topic is "Assessing the needs for support for patients in UK". Keen to see how we can cooperate with clinicians even more to further improve provision of info + support

    Prikaži ovu nit

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.